The efficacy of Dulaglutide in patients with diabetes undergoing hemodialysis.

The efficacy of Dulaglutide in patients with diabetes undergoing hemodialysis. - The efficacy of Dulaglutide in patients with diabetes undergoing hemodialysis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039525

Enrollment

Registered

2020-02-18

Start date

2016-03-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with diabetes undergoing hemodialysis.

Interventions

Dulaglutide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients

Exclusion criteria

Exclusion criteria: Patients who are considered inappropriate for participation in this study by the investigator's judgement.

Design outcomes

Primary

Measure	Time frame
Glycoalbumin C-peptide levels	—

Secondary

Measure	Time frame
Number of drugs for diabetes treatment. Hypoglycemia	—

Countries

Japan

Contacts

Public ContactSatoshi Funakoshi

Nagasaki Kidney Hospital Depertment of nephrology

satoshi2754@yahoo.co.jp095-824-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026